Key result
Pulmonary vein stenting resolves post-ablation hemoptysis with 3-month patency in a single patient.
Why the study?
Pulmonary vein stenosis is an uncommon but under-recognized complication of radiofrequency catheter ablation for atrial fibrillation with significant morbidity and frequent misdiagnosis.
Case Report (n=1)
Pulmonary vein stenosis is an under-recognized complication of atrial fibrillation ablation that can present with nonspecific respiratory symptoms and is effectively treated with balloon angioplasty and stenting.
Answers are grounded in this paper and cite their sources.
PVS after AF ablation requires clinical vigilance to avoid misdiagnosis; leaves open prospective studies on screening and outcomes.
Pulmonary vein stenosis (PVS) is an uncommon, but under-recognized complication of radiofrequency catheter ablation (RFCA) for atrial fibrillation (AF), with significant associated morbidity.12 Misdiagnosis is common given a nonspecific clinical and radiographic presentation. Symptoms, if present, typically manifest within months of RFCA, and may include fatigue, cough, dyspnea, hemoptysis, and/or pleurisy.34 Pulmonary vein stenosis may be severe before symptom onset, necessitating an expedient diagnosis within the narrow window for therapeutic intervention. Among other complications, stenosis may progress to occlusion with complicating pulmonary infarction, which may require surgical lobectomy.45 Pulmonary vein angioplasty and stenting improve symptom burden and long-term outcomes, though restenosis remains relatively common.4 We present here a case of recurrent hemoptysis due to PVS after RFCA.Presentation: A 51-year-old man with remote exercise-induced asthma and a history of RFCA for paroxysmal AF presented to pulmonary clinic for evaluation of recurrent hemoptysis. Nonproductive cough, dyspnea, and diminished exercise tolerance had first manifest 18 months prior, with onset weeks after his RFCA. Symptoms were initially attributed to asthma, though dyspnea indolently progressed, with appreciable deterioration in his exertional capacity. Ultimately, his cough became periodically productive of blood, prompting specialty referral.Physical examination revealed a well-appearing, slightly overweight man with normal work of breathing. He was normotensive, with a normal heart rate, and resting pulse oximetry saturation of 94%. Auscultation revealed normal breath sounds, regular rhythm, and absence of murmur. No jugular venous distension or edema was appreciated.Workup and Therapeutic Interventions: Chemistries, coagulation parameters, and complete blood count were normal. Serial plain chest radiography showed fluctuating opacities in the left apex and a small, ipsilateral pleural effusion. Empiric oral antibiotics offered no benefit. Holter monitor confirmed maintenance of sinus rhythm. Transthoracic echocardiogram demonstrated concentric left ventricular hypertrophy, right ventricular systolic pressure of 30 mm Hg, normal chamber sizes, and no significant valve dysfunction. Pulmonary embolism was ruled out by chest computerized tomography (CT) angiogram, which otherwise revealed ground-glass opacities (GGO), nodular infiltrates, and interstitial prominence in the left upper lobe (LUL).Bronchoalveolar lavage was negative for hemorrhage, infection, or neoplasm. Airway inspection notably demonstrated focal edema and prominent vascularity throughout the LUL, raising suspicion for PVS. A cardiac-gated chest CT was obtained, which confirmed severe left upper pulmonary vein (LUPV) stenosis; additionally, progressive GGO, left pleural effusion, and increased peri-bronchovascular opacities were noted.The patient underwent right and trans-septal left heart catheterization, with balloon angioplasty and stenting of his focal ostial LUPV stenosis, resulting in symptomatic resolution. Repeat cardiac-gated chest CT performed 3 months later revealed stent patency, significant regression of left pleural effusion, and resolved LUL airspace disease.Discussion: Catheter ablation for AF, either by radiofrequency or cryoballoon, is an intervention with good results and an overall low complication rate.126 Awareness of PVS as a potential but uncommon complication is critical given the ubiquity of the procedure. Pulmonary vein stenosis is defined as a >20% reduction of pre-ablation pulmonary venous diameter, further classified as mild when luminal narrowing is 20% to 49%, moderate when 50% to 69%, and severe when exceeding 70%.2 Symptom burden is related to both severity of stenosis and number of vessels involved.48 Notably, patients may remain asymptomatic with single-vessel stenosis, even with complete occlusion,8 due to collateral formation and compensatory shifts in the pulmonary circulation.Familiarity with the RFCA procedure facilitates understanding of the anatomic basis of PVS. In the modern approach to RFCA, transmural scar is induced in the left atrium, surrounding the vessel ostia, to electrically “isolate” the pulmonary veins, as the majority of AF electrically originates within these vessels. To halt propagation of ectopy, RFCA typically involves ablation surrounding all 4 veins, not just those demonstrated to be arrhythmogenic. In that anatomic context, PVS may involve multiple vessels. Incidence has declined with the above circumferential antral (vs within the ostia of the pulmonary veins) approach,6 and with use of intra-procedural 3-dimensional mapping to clarify anatomy.12 A cryoballoon approach may produce less PVS, but may be less effective, and with increased incidence of other complications.9 Despite advances, PVS continues to complicate 0% to 3%146 of RFCA ablations, requiring subsequent procedural intervention after 0.29% of ablations.1Pulmonary vein stenosis is frequently misdiagnosed,7 in part due to comorbid cardiopulmonary disease inherent in the atrial fibrillation population. Clinical presentation is nonspecific; symptoms include cough, fatigue, dyspnea, chest pain, and hemoptysis, and chest imaging most commonly demonstrates consolidation and effusion ipsilateral to stenosis. Working diagnoses of infection, malignancy, and embolism are commonly exhausted prior to consideration of PVS.4Cardiac-gated chest CT is the preferred noninvasive diagnostic approach to suspected PVS, while invasive venography remains the gold standard.4 Transesophageal (but not transthoracic) echocardiogram,8 lung perfusion (V/Q) scanning, and magnetic resonance (MR) perfusion imaging all have diagnostic value, though may be less sensitive than CT.4 When appropriately protocoled, MR has the added benefit to characterize effects of PVS on pulmonary arterial and right heart hemodynamics. Lung perfusion scanning affords a noninvasive means of assessing the functional significance of PVS.2 Of note, CT may overestimate severity of stenosis, suggesting complete occlusion when residual patency remains.4Holmes et al elaborate their experience as a large referral center for PVS, and express concern for a trend away from routine CT imaging before and after ablation to monitor for PVS, describing later detection and increasing occlusive disease.8 Complete occlusion, which can be both rapid and unpredictable,8 may manifest with signs of infarction: severe chest pain, frank hemoptysis, or pleurisy. In this setting, percutaneous intervention may no longer be feasible, and surgical lobectomy may be required.5Pulmonary vein stenosis, with or without symptoms, may also be treated to prevent myriad other complications, including recurrent pneumonia, hemorrhage, pulmonary hypertension, or in situ thrombosis. Early intervention in symptomatic PVS improves symptoms and long-term outcomes.4 In asymptomatic patients, CT angiograms demonstrating severe disease or multivessel disease warrant consideration of invasive angiography, or further imaging to clarify functional significance.2 For those undergoing angiographic intervention, the majority will have immediate resolution of symptoms; even asymptomatic patients typically describe an improvement in functional capacity after stenting.4 Major adverse events of intervention are rare, but include pulmonary hemorrhage, tamponade, pulmonary vein injury, and embolic cerebrovascular events.34 Unfortunately, approximately 25% of patients may experience restenosis after stenting, and more after balloon angioplasty alone.4 For this reason, close radiographic and clinical surveillance is warranted to prevent further complications.Teaching PointsMentoring comments:The differential diagnosis for dyspnea and hemoptysis is diverse, and potential underlying causes may be associated with significant morbidity and mortality. The radiographic manifestations of waxing and waning opacities and septal thickening isolated to the LUL suggested a focal process involving the pulmonary veins or lymphatics. A thorough history along with the radiographic manifestations was critical in connecting this patient's presentation to his prior RFCA procedure, leading to diagnosis via cardiac-gated CT angiography and subsequent treatment with balloon dilatation and stenting.
No takes yet. Share an insight, caveat, or question.
Levine et al. (2018) conducted a case report in Pulmonary vein stenosis after atrial fibrillation ablation (n=1). Balloon angioplasty and stenting was evaluated on Symptomatic resolution and stent patency. Balloon angioplasty and stenting of focal ostial left upper pulmonary vein stenosis resulted in symptomatic resolution and stent patency at 3 months in a patient with post-ablation hemoptysis.
Synapse has enriched 10 related papers. Consider them for comparative context: